Massive Recall of Blood Pressure Medication: What You Need to Know

A critical mistake by an unregulated manufacturer has prompted a massive recall of a widely used blood pressure medication. Approximately 600,000 bottles of Ramipril capsules are being pulled from shelves due to concerns over possible contamination. The affected medication comes in strengths of 2.5 mg, 5 mg, and 10 mg.

Ramipril is commonly prescribed to treat hypertension by opening up blood vessels and reducing heart pressure. It’s often administered after a heart attack to help manage blood pressure. However, the recall has raised concerns among patients who rely on this medication to manage their condition.

The issue stems from an ingredient sourced from a factory in India, which failed to conduct proper checks on its suppliers. Although the FDA considers the risk of contamination to be low, the agency is erring on the side of caution. Fortunately, there have been no reported adverse effects so far.

If you’re taking Ramipril, it’s essential to check your medication to see if it’s part of the recall. The affected bottles were manufactured by Lupin Pharmaceuticals, an Indian company, and come in strengths of 2.5 mg, 5 mg, and 10 mg. The recalled bottles have a sell-by date up to July 2026 and were sold in bottles of 90, 10, and 150.

To ensure your safety, it’s best to discard any recalled medication and consult with your healthcare provider or pharmacist for guidance on alternative treatments.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *